Bulletin
Investor Alert

New York Markets After Hours

Harrow Health Inc.

NAS: HROW

GO
/marketstate/country/us

Market closed

 --Quotes are delayed by 20 min

Dec 1, 2021, 4:00 p.m.

/zigman2/quotes/206805265/composite

$

9.97

Change

-0.03 -0.30%

Volume

Volume 71,135

Quotes are delayed by 20 min

/zigman2/quotes/206805265/composite

Previous close

$ 10.00

$ 9.97

Change

-0.03 -0.30%

Day low

Day high

$9.52

$10.25

Open

52 week low

52 week high

$5.13

$12.99

Open

Robert J. Kammer

Founder of Harrow Health, Inc., Robert J. Kammer presently holds the position of Co-Chairman for Softscience, Inc. (United States) and Chairman of Harrow Health, Inc.

In the past he held the position of Member of Osseointegration Study Club of Southern California, Associate Professor at The University of Colorado School of Medicine and Founding Member at Academy For Sports Dentistry.

Dr. Kammer received an undergraduate degree from Xavier University and a doctorate from the University of Iowa College of Dentistry.

Transactions

Date Shares Transaction Value
11/11/2019 6,500   Disposition at $4.75 per share. 30,875
10/07/2019 6,500   Disposition at $5.25 per share. 34,125
09/09/2019 6,500   Disposition at $5.67 per share. 36,855
08/12/2019 6,500   Disposition at $6.89 per share. 44,785
07/15/2019 6,500   Disposition at $7.91 per share. 51,415
06/03/2019 10,000   Disposition at $5.78 per share. 57,800
05/01/2019 10,000   Disposition at $4.57 per share. 45,700
04/01/2019 10,000   Disposition at $4.77 per share. 47,700
03/01/2019 10,000   Disposition at $6.91 per share. 69,100
02/01/2019 10,000   Disposition at $5.86 per share. 58,600
01/02/2019 10,000   Disposition at $5.33 per share. 53,300
12/03/2018 10,000   Disposition at $4.64 per share. 46,400
11/01/2018 10,000   Disposition at $4.21 per share. 42,100
10/15/2018 10,000   Disposition at $3 per share. 30,000
09/04/2018 10,000   Disposition at $3 per share. 30,000
08/10/2018 130,000   Disposition at $3 per share. 390,000
07/17/2017 10,000   Disposition at $3.05 per share. 30,500
03/09/2017 20,000   0

Officers and Executives

Mr. Mark L. Baum
Chairman & Chief Executive Officer
Mr. Andrew R. Boll
Chief Financial Officer & Secretary
Dr. Larry M. Dillaha
Chief Medical Officer
Mr. Andrew Livingston
Chief Innovation Officer
Mr. John P. Saharek
President-ImprimisRx
Dr. Richard L. Lindstrom
Director
Ms. Teresa F. Sparks
Independent Director
Dr. R. Lawrence Van Horn
Independent Director
Dr. Robert J. Kammer
Independent Director
Trending Tickers
  • /zigman2/quotes/200467500/composite NVDA+6.01%
  • /zigman2/quotes/200164174/composite SNOA+85.40%
  • /zigman2/quotes/202092269/composite ENSC+35.46%
  • /zigman2/quotes/226465160/composite ALF-14.72%
  • /zigman2/quotes/207732364/composite MSFT+1.66%
X
Powered by StockTwits
Link to MarketWatch's Slice.